Continuous Assessment of Hemodynamic Compensation in Pediatric Trauma Patients

Description

This is an observation study using the Flashback CRI T1 tablet to collect data on compensatory reserve index in pediatric trauma patients. Highest trauma activations at the institution will be enrolled in the study and data will be collected for 12-24 hours based on the patient's hemodynamic status. The device collects data via a pulse oximeter probe. No treatment decisions will be made based on the values of the on the CRI tablet. Data will be retrospectively reviewed to determine if any trends exist that correlate with blood loss, need for operation or blood transfusion.

Conditions

Trauma

Study Overview

Study Details

Study overview

This is an observation study using the Flashback CRI T1 tablet to collect data on compensatory reserve index in pediatric trauma patients. Highest trauma activations at the institution will be enrolled in the study and data will be collected for 12-24 hours based on the patient's hemodynamic status. The device collects data via a pulse oximeter probe. No treatment decisions will be made based on the values of the on the CRI tablet. Data will be retrospectively reviewed to determine if any trends exist that correlate with blood loss, need for operation or blood transfusion.

Continuous Assessment of Hemodynamic Compensation in Pediatric Trauma Patients

Continuous Assessment of Hemodynamic Compensation in Pediatric Trauma Patients

Condition
Trauma
Intervention / Treatment

-

Contacts and Locations

Aurora

Children's Hospital Colorado, Aurora, Colorado, United States, 80045

Washington

Children's National Hospital, Washington, District of Columbia, United States, 20010

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Pregnant patients
  • * Incarcerated patients
  • * Patients who object to study participation at any time
  • * Limited access to or compromised monitoring sites for non-invasive finger sensors
  • * Brain death (GCS 3 with fixed, dilated pupils)

Ages Eligible for Study

31 Days to 26 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Colorado, Denver,

Steven L Moulton, MD, PRINCIPAL_INVESTIGATOR, Children's Hospital Colorado

Study Record Dates

2024-06-30